{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} MRI of Hypoxia in Primary Central Nervous System Tumors: Part II - Vol. 40, No. 13

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Assess the variety of tracers developed to evaluate features of tumor biology, including hypoxia, oxygen metabolism, cerebral blood flow, and oxygen extraction fraction.
  2. Analyze the role of [18F]-fluoromisonidazole in prediction of patient prognosis, tumor grade, and treatment response in gliomas.
  3. Distinguish how multimodal positron emission tomography imaging simultaneously evaluates hypoxia and metabolism.
Price: $49.00

Credits:

  • ACCME 2.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: CNE0918
Published: September 15, 2018
Expires: 1/1/2026
Required Passing Score: 7/10 (70%)
Authors: Michael Karsy, MD, PhD, MSc, David L. Gillespie, PhD, Kevin Horn, MD, PhD, Jonathan B. Harper, BS, Michael Ruesch, BS, Jeffrey T. Yap, PhD, and Randy L. Jensen MD, PhD
Categories: Tumor
Specialties: Neurological Surgery